Arrowhead Research | ARWR - Market Capitalization


Arrowhead Research reported $7.99B in Market Capitalization this October of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Alnylam Pharmaceuticals USD 40.19B 3.96B Jun/2026
Anika Therapeutics USD 139M 3M Dec/2025
Arrowhead Research USD 11.5B 2.72B Jun/2026
Heron Therapeutics USD 238M 7M Dec/2025
Incyte USD 22.65B 3.92B Jun/2026
Ionis Pharmaceuticals USD 13.1B 642M Jun/2026
Ligand Pharmaceuticals USD 6.34B 2.35B Jun/2026
Merck USD 317.37B 20.27B Jun/2026
Nektar Therapeutics USD 2.12B 1.26B Mar/2026
Novartis USD 240.59B 67.17B Jun/2026
Sarepta Therapeutics USD 1.9B 388M Jun/2026
TG Therapeutics USD 8.41B 3.1B Jun/2026
Ultragenyx Pharmaceutical USD 3.29B 1.23B Jun/2026
Vertex Pharmaceuticals USD 126.07B 12.49B Jun/2026
Xencor USD 1.19B 301M Jun/2026